Burg Simpson Shareholders Published in “Trial Magazine”
Burg Simpson shareholders Janet Abaray and David Harman were recently published in the January 2020 issue of Trial magazine. In 2019 the U.S. Supreme Court decided Merck Sharp & Dohme Corp. v. Albrecht, which provided clarity on the difficult standard drug makers must meet to prove the affirmative defense of impossibility preemption. In their article, Navigating Preemption after Merck, Ms. Abaray and Mr. Harman analyze this decision and provide attorneys with practical guidance on how to develop their pharmaceutical cases and use Merck to defeat preemption and simplify the issues at trial.
Read article here: Trial_2020Jan_Abaray
Burg Simpson shareholder Janet Gilligan Abaray acts as managing shareholder for the Cincinnati office of Burg Simpson Eldredge Hersh & Jardine, P.C. Ms. Abaray has litigated extensively in the area of pharmaceutical products liability, and also represents plaintiffs in many insurance and contract disputes. Ms. Abaray has been selected by members of the national legal community as one of the Best Lawyers in America for Mass Tort Litigation since 2011. She has also received a Top 15 Business Woman in Ohio award by the National Diversity Council, and the University of Cincinnati College of Arts and Sciences recognized Ms. Abaray as its Distinguished Alumni for the 2018-2019 academic year.
Burg Simpson shareholder David Harman focuses his practice on personal injury, mass tort, and class action litigation. David has considerable experience representing individuals in complex products liability cases against some of the largest pharmaceutical and medical device manufacturers in the world. David is also experienced representing individuals in a variety of personal injury claims involving motor vehicle collisions, trucking accidents, and defective products. From 2014 to the present, David has been recognized by the National Trial Lawyers as one of the Top 40 under 40 Attorneys in Ohio and was selected as a Rising Star by Super Lawyers from 2017 – 2019.
Burg Simpson Simpson Eldredge Hersh & Jardine currently has more than 60 trial attorneys who provide nationwide legal representation. The firm is based in Colorado and has offices in Arizona, Ohio, Wyoming, New Mexico, Nevada, and Florida. Burg Simpson’s award-winning trial lawyers represent clients with legal matters that range from business and commercial litigation, construction defects, mass torts, and medical malpractice, to personal injury and workers’ compensation.
Founded in 1976, Burg Simpson has proven track record of success and has collected over $1 billion in verdicts, judgments, and settlements on behalf of its clients. Burg Simpson’s attorneys have been named as national lead counsel and earned federal court appointments in several cases, such as YAZ/Yasmin®, Pradaxa®, Ortho Evra®, Gadolinium-based contrast agents, Heparin, DePuy ASR®, Bextra/Celebrex, Zyprexa®, and testosterone replacement therapy.
Over the past four decades, Burg Simpson’s highly-skilled and results-driven trial attorneys have gained a national reputation and the depth of experience necessary to garner significant awards. The firm has been consistently recognized for excellence by The Best Lawyers in America, Super Lawyers, Legal 500, 5280 Top Lawyers, The National Trial Lawyers, and the American Board of Trial Advocates.
Burg Simpson has spent over 40 years fighting for the legal rights of those harmed by the actions or inactions of negligent corporations and individuals. Our team of trial lawyers and legal professionals are dedicated to securing the compensation our clients deserve.